Literature DB >> 17805962

Differential affinities of Erythrina cristagalli lectin (ECL) toward monosaccharides and polyvalent mammalian structural units.

Albert M Wu1, June H Wu, Ming-Sung Tsai, Zhangung Yang, Nathan Sharon, Anthony Herp.   

Abstract

Previous studies on the carbohydrate specificities of Erythrina cristagalli lectin (ECL) were mainly limited to analyzing the binding of oligo-antennary Galbeta1-->4GlcNAc (II). In this report, a wider range of recognition factors of ECL toward known mammalian ligands and glycans were examined by enzyme-linked lectinosorbent and inhibition assays, using natural polyvalent glycotopes, and a glycan array assay. From the results, it is shown that GalNAc was an active ligand, but its polyvalent structural units, in contrast to those of Gal, were poor inhibitors. Among soluble natural glycans tested for 50% molecular mass inhibition, Streptococcus pneumoniae type 14 capsular polysaccharide of polyvalent II was the most potent inhibitor; it was 2.1 x 10(4), 3.9 x 10(3) and 2.4 x 10(3) more active than Gal, tri-antennary II and monomeric II, respectively. Most type II-containing glycoproteins were also potent inhibitors, indicating that special polyvalent II and Galbeta1-related structures play critically important roles in lectin binding. Mapping all information available, it can be concluded that: [a] Galbeta1-->4GlcNAc (II) and some Galbeta1-related oligosaccharides, rather than GalNAc-related oligosaccharides, are the core structures for lectin binding; [b] their polyvalent II forms within macromolecules are a potent recognition force for ECL, while II monomer and oligo-antennary II forms play only a limited role in binding; [c] the shape of the lectin binding domains may correspond to a cavity type with Galbeta1-->4GlcNAc as the core binding site with additional one to four sugars subsites, and is most complementary to a linear trisaccharide, Galbeta1-->4GlcNAcbeta1-->6Gal. These analyses should facilitate the understanding of the binding function of ECL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805962     DOI: 10.1007/s10719-007-9063-y

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  46 in total

1.  Immunochemical studies on blood groups. XXII. Immunochemical studies on the nondialyzable residue from partially hydrolyzed blood group A, B and O(H) substances (P1 fractions).

Authors:  P Z ALLEN; E A KABAT
Journal:  J Immunol       Date:  1959-04       Impact factor: 5.422

2.  The biotin/avidin-mediated microtiter plate lectin assay with the use of chemically modified glycoprotein ligand.

Authors:  M Duk; E Lisowska; J H Wu; A M Wu
Journal:  Anal Biochem       Date:  1994-09       Impact factor: 3.365

3.  Immunochemical studies on blood groups: The internal structure and immunological properties of water-soluble human blood group A substance studied by Smith degradation, liberation, and fractionation of oligosaccharides and reaction with lectins.

Authors:  A M Wu; E A Kabat; M E Pereira; F G Gruezo; J Liao
Journal:  Arch Biochem Biophys       Date:  1982-05       Impact factor: 4.013

4.  Immunochemical studies on the combining site of the D-galactose/N-acetyl-D-galactosamine specific lectin from Erythrina cristagalli seeds.

Authors:  P M Kaladas; E A Kabat; J L Iglesias; H Lis; N Sharon
Journal:  Arch Biochem Biophys       Date:  1982-09       Impact factor: 4.013

5.  Further characterization of the binding properties of a GalNAc specific lectin from Codium fragile subspecies tomentosoides.

Authors:  A M Wu; S C Song; S C Chang; J H Wu; K S Chang; E A Kabat
Journal:  Glycobiology       Date:  1997-12       Impact factor: 4.313

6.  Selective inhibition of N-acetylglucosamine and galactose-specific lectins including the 14-kDa vertebrate lectin by novel synthetic biantennary oligosaccharides.

Authors:  D Gupta; S Sabesan; C F Brewer
Journal:  Eur J Biochem       Date:  1993-09-15

Review 7.  Carbohydrate structural units in glycoproteins and polysaccharides as important ligands for Gal and GalNAc reactive lectins.

Authors:  Albert M Wu
Journal:  J Biomed Sci       Date:  2003 Nov-Dec       Impact factor: 8.410

8.  Current concepts of the structure and nature of mammalian salivary mucous glycoproteins.

Authors:  A Herp; A M Wu; J Moschera
Journal:  Mol Cell Biochem       Date:  1979-01-15       Impact factor: 3.396

9.  Characterization of binding of Gal beta 4GlcNAc-specific lectins from Erythrina cristagalli and Erythrina corallodendron to glycosphinogolipids. Detection, isolation, and characterization of a novel glycosphinglipid of bovine buttermilk.

Authors:  S Teneberg; J Angström; P A Jovall; K A Karlsson
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

10.  Immunochemical studies on blood groups; chemical changes associated with destruction of blood group activity and enhancement of the type XIV cross-reactivity by partial hydrolysis of hog and human blood group A, B, and O substances.

Authors:  E A KABAT; H BAER
Journal:  J Exp Med       Date:  1948-07       Impact factor: 14.307

View more
  20 in total

1.  Combining 3D structure with glycan array data provides insight into the origin of glycan specificity.

Authors:  Oliver C Grant; Matthew B Tessier; Lawrence Meche; Lara K Mahal; Bethany L Foley; Robert J Woods
Journal:  Glycobiology       Date:  2016-02-23       Impact factor: 4.313

2.  Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis.

Authors:  Ramray Bhat; Brian Belardi; Hidetoshi Mori; Peiwen Kuo; Andrew Tam; William C Hines; Quynh-Thu Le; Carolyn R Bertozzi; Mina J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-05       Impact factor: 11.205

3.  Antibody blood-brain barrier efflux is modulated by glycan modification.

Authors:  John M Finke; Kari R Ayres; Ryan P Brisbin; Hali A Hill; Emily E Wing; William A Banks
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-06-15       Impact factor: 3.770

4.  Microarray analyses of closely related glycoforms reveal different accessibilities of glycan determinants on N-glycan branches.

Authors:  Lei Li; Wanyi Guan; Gaolan Zhang; Zhigang Wu; Hai Yu; Xi Chen; Peng G Wang
Journal:  Glycobiology       Date:  2020-04-20       Impact factor: 4.313

5.  Terminal N-linked galactose is the primary receptor for adeno-associated virus 9.

Authors:  Shen Shen; Kelli D Bryant; Sarah M Brown; Scott H Randell; Aravind Asokan
Journal:  J Biol Chem       Date:  2011-02-17       Impact factor: 5.157

6.  Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A Virus.

Authors:  Meiling Dai; Ryan McBride; Jos C F M Dortmans; Wenjie Peng; Mark J G Bakkers; Raoul J de Groot; Frank J M van Kuppeveld; James C Paulson; Erik de Vries; Cornelis A M de Haan
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

7.  Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure.

Authors:  Wei Deng; Andrew R Ednie; Jianyong Qi; Eric S Bennett
Journal:  Basic Res Cardiol       Date:  2016-08-09       Impact factor: 17.165

Review 8.  Lectins as tools in glycoconjugate research.

Authors:  Albert M Wu; Elwira Lisowska; Maria Duk; Zhangung Yang
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

9.  Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.

Authors:  Wenjuan Du; Meiling Dai; Zeshi Li; Geert-Jan Boons; Ben Peeters; Frank J M van Kuppeveld; Erik de Vries; Cornelis A M de Haan
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

10.  Defining the Specificity of Carbohydrate-Protein Interactions by Quantifying Functional Group Contributions.

Authors:  Amika Sood; Oksana O Gerlits; Ye Ji; Nicolai V Bovin; Leighton Coates; Robert J Woods
Journal:  J Chem Inf Model       Date:  2018-08-22       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.